CD47 and neoplasm: The application of ICD activation and CD47 blockade strengthened T-cell – mediated reaction, DC maturation tolerance to antitumor, resulting in clinical outcomes, tumor metastasis, and tumor relapse prevention (Gao et al., 2019).